Article info
PDFReview
Wegovy (semaglutide): a new weight loss drug for chronic weight management
- Correspondence to Dr Gurdeep Singh, Our Lady of Lourdes Memorial Hospital, Binghamton, NY 13905, USA; drgsingh803{at}gmail.com
Citation
Wegovy (semaglutide): a new weight loss drug for chronic weight management
Publication history
- Accepted October 6, 2021
- First published October 27, 2021.
Online issue publication
December 23, 2021
Article Versions
- Previous version (27 October 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Federation for Medical Research 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.